Optimizing Therapy: Current and Emerging Treatment Options for Osteoporosis
Treatment of patients with osteoporosis varies widely and some health care providers may not be aware of all the current and emerging treatment options available for this disease. Better education regarding the use of biomarkers will enable health care providers to make better treatment decisions. Learning objectives of this CME webinar include:

• Evaluate recent recommendations for the use of nonpharmacologic agents such as vitamin D, calcium, and exercise in patients with osteoporosis
• Develop a plan to address high-profile patient concerns such as subtrochanteric fractures of the femoral shaft, osteonecrosis of the jaw, and osteosarcoma related to pharmacologic agents frequently used to treat osteoporosis
• Discuss data that supports current unmet needs in the treatment of patients with osteoporosis
• Explain the potential role of late-stage pipeline agents under investigation for the treatment of osteoporosis.

» Go to this activity

Identifying Patients at High Risk for Fractures
This earlier CME webinar, the first in a related series for obstetricians/gynecologists and other healthcare professionals who have an interest in the treatment and management of osteoporosis, complements the one above. » Go to this activity

You are subscribed to ModernMedicine.com. To unsubscribe, click here

To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.